It's National Muscular Dystrophy Awareness Month. How many ways can you make a difference in September?

Medical Educational Resource

We're accelerating the delivery of treatments and cures.

Myasthenia Gravis: Clinical Features and Differential Diagnosis

Activity Snapshot

Activity Type: 
On-Demand Webinar
Release Date: 
Wednesday, August 7, 2024
Expiration Date: 
Thursday, August 7, 2025

Faculty

Shruti Raja, MD
Assistant Professor of Neurology, Faculty Director of Duke Early Phase Research Unit, Co-Medical Director of Duke Clinical Research at Pickett Road

Duke University Medical Center

Ryan Kollar, DO
Neuromuscular Fellow

Duke University Medical Center

Activity Overview: 

This webinar will provide a brief disease overview, including symptoms pathophysiology, discuss diagnostic testing modalities and differential diagnosis, and will explore challenging diagnostic and management scenarios using case examples.

Download Clinician Flashcard

Learning Objectives: 

Upon completion of the educational activity, participants should be able to:

  • Recognize the signs and symptoms of MG.
  • Identify the testing modalities to utilize when encountering a patient with suspected MG.
  • Recommend a treatment plan to patients based on evidence-based guidelines and incorporating knowledge of up-to-date treatment options.
  • Discuss referring patients with diagnosed MG to relevant specialists for supportive care.
  • Accreditation and Designation Statement: 

    CE credit provided by AKH Inc., Advancing Knowledge in Healthcare.

    In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and MDA. AKH Inc., Advancing Knowledge in Healthcare is jointly
    accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    See full accreditation and designation statements and disclosure here

    How to Obtain CME credits : 

    To obtain a certificate of completion, a score of 70% or better on the post-test is required. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your certificate. You must participate in the entire activity to receive credit. There is no fee to participate in this activity. If you have questions about this activity, please contact AKH Inc. at wendi@akhcme.com.

    Complete Evaulation Form

    Faculty Disclosures: 

    Shruti M. Raja, MD: Consultant; Regeneron, Ocaro Pharmaceuticals
    Ryan Kollar, DO: N/A, Nothing to disclose
    Dorothy Caputo, MA, BSN, RN - VP, Healthcare Continuing Education and Operations: N/A, Nothing to disclose
    Bernadette Makar, MSN, APRN-BC, NP-C (planner/reviewer): N/A, Nothing to disclose
    Dorothy Duffy, RPh (planner/reviewer): N/A, Nothing to disclose
    Broc Pollinger, MSW, LSW, OSW-C, (planner/reviewer): N/A, Nothing to disclose
    AKH Inc Staff and Planners: N/A, Nothing to disclose
    MDA Staff and Planners: N/A, Nothing to disclose

    All of the relevant financial relationships listed for these individuals have been mitigated.

    Disclosures:
    It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.

    Disclosure of Unlabeled Use and Investigational Product
    This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

    Disclaimer:
    This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content. If you would like to opt out from future communications from AKH please send an email to optout@akhcme.com with your information with "Opt Out" in the subject line.